Determinant of the effectiveness of GLP-1 in type 2 diabetes

被引：0
|
作者：
Toft-Nielsen, MB
Madsbad, S
Damholt, MB
Holst, JJ
机构：
来源：
DIABETES | 2000年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
516
引用
收藏
页码：A127 / A127
页数：1
相关论文
共 50 条
  • [21] A novel GLP-1 analog, a dimer of GLP-1 via covalent linkage by a lysine, prolongs the action of GLP-1 in the treatment of type 2 diabetes
    Pan, Yingying
    Shi, Siwei
    Lao, Xun
    Zhang, Jinlong
    Tan, Shiming
    Wu, Zirong
    Huang, Jing
    PEPTIDES, 2017, 88 : 46 - 54
  • [22] GLP-1 Agonists in Type 1 Diabetes Mellitus
    Janzen, Kristin M.
    Steuber, Taylor D.
    Nisly, Sarah A.
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (08) : 656 - 665
  • [23] EVALUATING THE COST-EFFECTIVENESS OF GLP-1 RECEPTOR AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES IN THE UK
    Ashley, D.
    Vega, G.
    Hunt, B.
    Valentine, W. J.
    VALUE IN HEALTH, 2015, 18 (07) : A606 - A606
  • [24] Polymorphisms of GLP-1 Receptor Gene and Response to GLP-1 Analogue in Patients with Poorly Controlled Type 2 Diabetes
    Lin, Chia-Hung
    Lee, Yun-Shien
    Huang, Yu-Yao
    Hsieh, Sheng-Hwu
    Chen, Zih-Syuan
    Tsai, Chi-Neu
    JOURNAL OF DIABETES RESEARCH, 2015, 2015
  • [25] Are all GLP-1 agonists equal in the treatment of type 2 diabetes?
    Nauck, Michael A.
    Meier, Juris J.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2019, 181 (06) : R211 - R234
  • [26] GLP-1 Medication Use for Type 2 Diabetes Has Soared
    Hegland, Thomas A.
    Fang, Zhengyi
    Bucher, Karen
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (12): : 952 - 953
  • [27] Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity
    Drucker, Daniel J.
    DIABETES CARE, 2024, 47 (11)
  • [28] GLP-1 agonists for type 2 diabetes: pharnnacokinetic and toxicological considerations
    Jespersen, Maria J.
    Knop, Filip K.
    Christensen, Mikkel
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (01) : 17 - 29
  • [29] Dulaglutide, a GLP-1 receptor agonist, for the treatment of type 2 diabetes
    Clements, Jennifer
    Moore, Katherine
    Shealy, Kayce
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2015, 10 (06) : 581 - 590
  • [30] The role of GLP-1 in the postprandial effects of acarbose in type 2 diabetes
    Dalsgaard, Niels B.
    Gasbjerg, Laerke S.
    Hansen, Laura S.
    Hansen, Nina L.
    Stensen, Signe
    Hartmann, Bolette
    Rehfeld, Jens F.
    Holst, Jens J.
    Vilsboll, Tina
    Knop, Filip K.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 184 (03) : 383 - 394
12345